➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
McKesson
Dow
Harvard Business School
Medtronic

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Patent: 5,741,663

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,741,663
Title: Selective additive and media for Pseudomonas fluorescens
Abstract:The present invention provides methods and compositions for the specific detection of Pseudomonas fluorescens and for the selective growth of this bacterium. In a preferred embodiment, selective growth of P. fluorescens is effected by the combination of Irgasan, carbenicillin and nitrofurantoin in a bacteriological medium comprising suitable nutrients for its growth. Also provided is a fast, reliable and economical method for the assessment of microbial quality of a fresh animal product, such as poultry, beef, fish, shellfish, milk or the like, using media selective for the growth of P. fluorescens and detection methods for microbial growth in the selective media.
Inventor(s): Russell; Scott Marshall (Athens, GA)
Assignee: University of Georgia Research Foundation, Inc. (Athens, GA)
Application Number:08/632,929
Patent Claims:see list of patent claims

Details for Patent 5,741,663

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial University of Georgia Research Foundation, Inc. (Athens, GA) 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial University of Georgia Research Foundation, Inc. (Athens, GA) 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Mallinckrodt
Medtronic
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.